Sykehuset Innlandet HF   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Brumunddal Norway (2001)

Organization Overview

First Clinical Trial
2001
NCT00257790
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Innlandet Hospital, Norway | Innlandet Hospital Trust Lillehammer | Innlandet Hospital Trust Lillehammer, Neurological Department | Innlandet Hospital Trust, Postboks 104, 2381 Brumunddal, Norway | Innlandet Hospital Trust, Reinsvoll | Innlandet Hospital Trust, Sanderud | Medi 3 Innlandet AS, avd Hamar | Sykehuset Innlandet HF | Tor A. Strand